Salvatore Pernagallo is a highly experienced professional currently serving as Chief Technology Officer at DESTINA Genomica SL since March 2012, where responsibilities include overseeing technology development and identifying new product opportunities. As a co-founder and co-owner of NanoGetic SL, engagement focuses on managing scientific and technological activities, particularly the "HyaluSphere" project. Salvatore also functions as an Olympic Referee for United World Wrestling since 2010. Prior academic experience includes postdoctoral research at the University of Edinburgh, concentrating on polymer libraries for hepatocyte differentiation and biopolymers for intra-vascular devices. Educational qualifications include a PhD in Molecular Biology from The University of Edinburgh, a specialization in Medical Genetics, and an MSc in Molecular Biology from Università di Catania.
Sign up to view 0 direct reports
Get started